Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 301–400 of 1,003
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Cunha, C., Gomes, C., Vaz, A. R., & Brites, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6986175 · Cited by 153
“Moreover, low CX3CR1 is associated with marked neuronal loss after systemic inflammation [11] and facilitates sepsis-induced immunosuppression resulting from monocyte inability to recognize CX3CL1 and kill pathogenic microorganisms [63].”
Cellular and Molecular Characterization of Microglia: A Unique Immune Cell Population
Sousa, C., Biber, K., & Michelucci, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00198 · Cited by 153
“However, although homozygous CX3CR1 deficiency dysregulates microglial responses resulting in neurotoxicity (108), no microglial phenotype has been so far reported for heterozygote animals when compared to mice harboring the GFP transgene under the Iba1 promoter (109, 110).”
BackgroundDysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
“CX3CR1 CX3CL1 Reduced signaling: PD, ALS [91]”
BackgroundInfluentialCorona, A. W., Norden, D. M., Skendelas, J. P., Huang, Y., O’Connor, J. C., Lawson, M., Dantzer, R., Kelley, K. W., & Godbout, J. P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.008 · Cited by 152
“, 1997) establishes a unique communication system whereby neurons constitutively express CX3CL1 to regulate the activation of microglia (Cardona et al., 2006).”
BackgroundResultInfluentialPrimary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration
Neher, J. J., Neniskyte, U., & Brown, G. C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00027 · Cited by 152
Barcia, C., Ros, C. M., Annese, V., Carrillo-de Sauvage, M. A., Ros-Bernal, F., Gómez, A., Yuste, J. E., Campuzano, C. M., de Pablos, V., Fernandez-Villalba, E., et al. (2012) · Scientific Reports · doi:10.1038/srep00809 · Cited by 150
Kaur, T., Zamani, D., Tong, L., Rubel, E. W., Ohlemiller, K. K., Hirose, K., & Warchol, M. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2325-15.2015 · Cited by 166
“Among these, fractalkine (CX3CL1) has been shown to promote activation and recruitment of monocytes and microglia (Cardona et al., 2006; Auffray et al., 2007; Ransohoff et al., 2007; Fuhrmann et al., 2010).”
BackgroundInfluentialCX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
Held‐Feindt, J., Hattermann, K., Müerköster, S. S., Wedderkopp, H., Knerlich‐Lukoschus, F., Ungefroren, H., Mehdorn, H. M., & Mentlein, R. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.018 · Cited by 154
Microglial signalling mechanisms: Cathepsin S and Fractalkine
Clark, A. K., & Malcangio, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.012 · Cited by 164
“Thus the suggestion is that under severe CNS injury CX3CR1 activation by FKN regulates microglial protective roles through intracellular PI3K signalling resulting in inhibition of both pro-inflammatory cytokine synthesis and microglial apoptosis (Cardona et al., 2006).”
BackgroundOntogeny and Functions of Central Nervous System Macrophages
Katsumoto, A., Lu, H., Miranda, A. S., & Ransohoff, R. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400716 · Cited by 149
“CX3CR1, CD200 paired with microglial CD200R1, CD22 with microglial CD45; and CD47 with microglial CD172a/ SIRPa (25) and TREM2b (1, 26).”
BackgroundInfluentialSelf-citationBarrientos, R. M., Frank, M. G., Crysdale, N. Y., Chapman, T. R., Ahrendsen, J. T., Day, H. E. W., Campeau, S., Watkins, L. R., Patterson, S. L., & Maier, S. F. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2266-11.2011 · Cited by 148
“Microglia are maintained in a quiescent state by ligation of either the fractalkine (CX(3)CR1) or CD200 receptor (Hoek et al., 2000; Cardona et al., 2006), both expressed on the microglial cell surface.”
BackgroundThe microglial networks of the brain and their role in neuronal network plasticity after lesion
Cullheim, S., & Thams, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.03.012 · Cited by 163
Mutant huntingtin impairs immune cell migration in Huntington disease
Kwan, W., Träger, U., Davalos, D., Chou, A., Bouchard, J., Andre, R., Miller, A., Weiss, A., Giorgini, F., Cheah, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64484 · Cited by 148
Vuong, B., Odero, G., Rozbacher, S., Stevenson, M., Kereliuk, S. M., Pereira, T. J., Dolinsky, V. W., & Kauppinen, T. M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0859-9 · Cited by 147
“In neurodegenerative disease models, CX3CR1 depletion was reported to sustain microglial inflammatory responses and degrade synaptic circuits, thus promoting neurodegeneration [65].”
BackgroundMorari, J., Anhe, G. F., Nascimento, L. F., de Moura, R. F., Razolli, D., Solon, C., Guadagnini, D., Souza, G., Mattos, A. H., Tobar, N., et al. (2014) · Diabetes · doi:10.2337/db13-1495 · Cited by 147
“Fractalkine (CX3CL1) is one of the most important chemokines that are involved in the regulation of neuroinflammatory conditions (13,14).”
BackgroundJoly, S., Francke, M., Ulbricht, E., Beck, S. C., Seeliger, M. W., Hirrlinger, P. G., Hirrlinger, J., Lang, K. S., Zinkernagel, M. S., Odermatt, B., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090023 · Cited by 161
What Do Microglia Really Do in Healthy Adult Brain?
Augusto-Oliveira, M., Arrifano, G. P., Lopes-Araújo, A., Santos-Sacramento, L., Takeda, P. Y., Anthony, D. C., Malva, J. O., & Crespo-Lopez, M. E. (2019) · Cells · doi:10.3390/cells8101293 · Cited by 145
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Su, X., Federoff, H. J., & Maguire-Zeiss, K. A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9053-x · Cited by 145
“It has been shown that neurons suppress microglial activation through the CX1CR3-fractalkine signaling pathway (Cardona et al. 2006).”
BackgroundRole of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 167
“Two neurodegenerative animal models of amyotrophic lateral sclerosis and Parkinson’s disease were studied in CX3CR1-deficient mice [28].”
BackgroundHuman iPSC‐derived microglia: A growing toolset to study the brain's innate immune cells
Hasselmann, J., & Blurton‐Jones, M. (2020) · Glia · doi:10.1002/glia.23781 · Cited by 145
“…that was included in the other medium formulations, Abud and colleagues further added in cytokines such as TGFβ, CX3CL1, CD200 which have all been shown to be critical for maintaining microglia homeostasis (Butovsky et al., 2014; Cardona et al., 2006; Hoek et al., 2000; Kierdorf & Prinz, 2013).”
BackgroundAlterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!
Estes, M. L., & McAllister, A. K. (2014) · Brain Pathology · doi:10.1111/bpa.12198 · Cited by 142
“In models of ischemia, which exhibit all four hallmarks of inflammation, increased expression of CX3CR1 is associated with microglial activation and recruitment to sites of injury and precipitates secondary neurodegeneration (19, 29, 52).”
BackgroundThe Role of Chemokines in the Pathophysiology of Major Depressive Disorder
Milenkovic, V. M., Stanton, E. H., Nothdurfter, C., Rupprecht, R., & Wetzel, C. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092283 · Cited by 144
“The CX3CL1 chemokine regulates microglial synaptic pruning of mature neurons [104], modulates several neurotransmitter systems [105], and regulates the activation state of microglia [85].”
BackgroundNoda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169839 · Cited by 144
Chitnis, T., Imitola, J., Wang, Y., Elyaman, W., Chawla, P., Sharuk, M., Raddassi, K., Bronson, R. T., & Khoury, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060677 · Cited by 164
“Fractalkine (CX3CL1) has recently been shown to play a regulatory role in CNS inflammation.(35) We found no significant differences in fractalkine expression in spinal cord homogenates between Wld and WT mice (Figure 7d).”
BackgroundPharmacological Targeting of Microglial Activation: New Therapeutic Approach
Liu, C.-Y., Wang, X., Liu, C., & Zhang, H.-L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 142
The Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion
Lee, Y. S., Morinaga, H., Kim, J. J., Lagakos, W., Taylor, S., Keshwani, M., Perkins, G., Dong, H., Kayali, A. G., Sweet, I. R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.001 · Cited by 141
Regulation of microglia development and homeostasis.
Greter, M., & Merad, M. (2013) · Glia · doi:10.1002/glia.22408 · Cited by 141
“…express high levels of CX3CR1 (fractalkine receptor), and it was shown that if microglia are unable to respond to the ligand CX3CL1 expressed by neurons, neurodegeneration was exacerbated suggesting that the fractal- GLIA kine receptor modulates microglia neurotoxicity (Cardona et al., 2006).”
BackgroundWhat is microglia neurotoxicity (Not)?
Biber, K., Owens, T., & Boddeke, E. (2014) · Glia · doi:10.1002/glia.22654 · Cited by 140
“rather high levels of free CX3CL1 in the brain (around 300 pg/mL), which is suggestive of constitutive CX3CL1 release under normal physiological conditions (Cardona et al., 2006).”
BackgroundChinnery, H. R., Ruitenberg, M. J., & McMenamin, P. G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181edbc1a · Cited by 140
“8C, E), which conformed to previous descriptions (13, 21, 27, 39, 40).”
BackgroundMethodThe PI3K/Akt pathway is required for LPS activation of microglial cells
Saponaro, C., Cianciulli, A., Calvello, R., Dragone, T., Iacobazzi, F., & Panaro, M. A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.665461 · Cited by 138
Lavalette, S., Raoul, W., Houssier, M., Camelo, S., Levy, O., Calippe, B., Jonet, L., Béhar‐Cohen, F., Chemtob, S., Guillonneau, X., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.013 · Cited by 145
Gao, H., Danzi, M. C., Choi, C. S., Taherian, M., Dalby-Hansen, C., Ellman, D. G., Madsen, P. M., Bixby, J. L., Lemmon, V. P., Lambertsen, K. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.11.083 · Cited by 138
“CX3CR1 seems to be involved in the communication between microglia and neurons which express CX3CL1, functioning as a microglial neurotoxicity suppressor (Cardona et al., 2006; Kim et al., 2011).”
Unique and shared inflammatory profiles of human brain endothelia and pericytes
Smyth, L. C. D., Rustenhoven, J., Park, T. I.-H., Schweder, P., Jansson, D., Heppner, P. A., O’Carroll, S. J., Mee, E. W., Faull, R. L. M., Curtis, M., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1167-8 · Cited by 136
Bhaskar, K., Maphis, N., Xu, G., Varvel, N. H., Kokiko-Cochran, O. N., Weick, J. P., Staugaitis, S. M., Cardona, A., Ransohoff, R. M., Herrup, K., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.007 · Cited by 137
Self-citationFunctional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Ising, C., & Heneka, M. T. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0153-x · Cited by 128
Macrophage signaling in HIV-1 infection
Herbein, G., Gras, G. S., Khan, K. A., & Abbas, W. (2010) · Retrovirology · doi:10.1186/1742-4690-7-34 · Cited by 157
“Moreover, Tat induces the expression of CCR3, CCR5 and CXCR4 in monocytes/macrophages in a concentration-dependent manner, possibly promoting HIV-1 infection [39].”
BackgroundInfluentialThe role of microglia in human disease: therapeutic tool or target?
Cartier, N., Lewis, C.-A., Zhang, R., & Rossi, F. M. V. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1330-y · Cited by 136
Luheshi, N. M., Kovács, K. J., Lopez-Castejon, G., Brough, D., & Denes, A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-186 · Cited by 136
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Finneran, D. J., & Nash, K. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1412-9 · Cited by 132
“CNS Drugs.”
BackgroundInfluentialMelchior, B., Garcia, A. E., Hsiung, B.-K., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN Neuro · doi:10.1042/an20100010 · Cited by 134
“For example, healthy neurons express ligands for inhibitory receptors such as CD200 receptor, CX3CR1 and CD45 (Mott et al., 2004; Cardona et al., 2006; Koning et al., 2009).”
BackgroundP2Y12R-Dependent Translocation Mechanisms Gate the Changing Microglial Landscape
Eyo, U. B., Mo, M., Yi, M.-H., Murugan, M., Liu, J., Yarlagadda, R., Margolis, D. J., Xu, P., & Wu, L.-J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.001 · Cited by 134
“Heterozygous (CX3CR1GFP/+) GFP reporter mice expressing GFP under control of the fractalkine receptor (CX3CR1) promoter (Jung et al., 2000) and transgenic mice (Thy1YFP/+) expressing YFP (Feng et al., 2000) in a subset of pyramidal neurons under the control of the Thy1 promoter were purchased from the Jackson Laborato…”
BackgroundInfluentialNG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis
Zhang, S.-Z., Wang, Q.-Q., Yang, Q.-Q., Gu, H.-Y., Yin, Y.-Q., Li, Y.-D., Hou, J.-C., Chen, R., Sun, Q.-Q., Sun, Y.-F., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1439-x · Cited by 135
“Previous studies have reported seemingly conflicting results regarding the effect of CX3CR1 on different brain disease pathologies [12, 52, 53].”
BackgroundResultInfluentialInflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 164
“Finally, anti-inflammatory roles have also been proven in mouse models, with the release of CX3CL1 and IL-33, decreasing microglia activation and promoting their anti-inflammatory phenotype [34, 263].”
Morganti, J. M., Nash, K. R., Grimmig, B. A., Ranjit, S., Small, B., Bickford, P. C., & Gemma, C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0539-12.2012 · Cited by 134
“As shown previously by Cardona et al. (2006), MPTP produced a larger lesion in the CX3CL1 / mice. sFKN treatment attenuated MPTP-induced dopaminergic cell loss compared to mFKN- (p 0.003) and GFP-treated (p 0.001) animals.”
BackgroundMethodInfluentialIdentification of early neurodegenerative pathways in progressive multiple sclerosis
Kaufmann, M., Schaupp, A.-L., Sun, R., Coscia, F., Dendrou, C. A., Cortés, A., Kaur, G., Evans, H. G., Mollbrink, A., Navarro, J. F., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01097-3 · Cited by 136
Planas, A. M. (2024) · Glia · doi:10.1002/glia.24501 · Cited by 152
“In cultured microglia, the pro-inflammatory shift induced by exposure to LPS triggers the accumulation of LDs (Khatchadourian et al., 2012).”
BackgroundInfluentialNoda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a110.169839 · Cited by 132
Schwartz, M., & Shechter, R. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.31 · Cited by 135
Bolton, J. L., Auten, R. L., & Bilbo, S. D. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.029 · Cited by 139
Inflammation in ALS and SMA: Sorting out the good from the evil
Papadimitriou, D., Le Verche, V., Jacquier, A., Ikiz, B., Przedborski, S., & Re, D. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 132
Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Trudler, D., Nazor, K. L., Eisele, Y. S., Grabauskas, T., Dolatabadi, N., Parker, J., Sultan, A., Zhong, Z., Goodwin, M. S., Levites, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025847118 · Cited by 131
“S3C); CSF1R and CX3CR1 expression are known to negatively correlate with proinflammatory activation (43, 44).”
BackgroundFractalkine Signaling and Microglia Functions in the Developing Brain
Arnoux, I., & Audinat, E. (2015) · Neural Plasticity · doi:10.1155/2015/689404 · Cited by 131
Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 131
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis
Haider, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/725370 · Cited by 154
“Signalling via these molecules, such as the fractalkine receptor ligand CX3CL1 [10], the membrane glycoprotein CD200 [40], the integrin associated protein myelin CD47 [41], and sialic acid alpha2,8-linked polysialic acids [42], inhibits microglial activation [43].”
BackgroundDangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells
Peter, C., Wesselborg, S., i, M. H., & Lauber, K. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0472-1 · Cited by 152
Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation
Manich, G., Recasens, M., Valente, T., Almolda, B., González, B., & Castellano, B. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.030 · Cited by 128
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
Mirzaei, N., Shi, H., Oviatt, M., Doustar, J., Rentsendorj, A., Fuchs, D.-T., Sheyn, J., Black, K. L., Koronyo, Y., & Koronyo-Hamaoui, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00921 · Cited by 128
Curcumin is a potent modulator of microglial gene expression and migration
Karlstetter, M., Lippe, E., Walczak, Y., Moehle, C., Aslanidis, A., Mirza, M., & Langmann, T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-125 · Cited by 127
“Ramified microglial cells actively scan their environment with their long protrusions [4,5] and continuous inhibitory signals from neurons prevent microglial toxicity [6,7].”
BackgroundBhalala, U. S., Koehler, R. C., & Kannan, S. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00144 · Cited by 126
The influence of environment and origin on brain resident macrophages and implications for therapy
Bennett, M. L., & Bennett, F. C. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0545-6 · Cited by 147
The brain’s best friend: microglial neurotoxicity revisited
Hellwig, S., Heinrich, A., & Biber, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00071 · Cited by 126
Piirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 136
Microglial phagocytosis in aging and Alzheimer's disease
Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127
“An imbalance in brain homeostasis takes place during aging, which constitutes the main risk factor for the development of neuro‐ degenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS) (Wyss‐Coray, 2016).”
BackgroundInfluentialGiunti, D., Marini, C., Parodi, B., Usai, C., Milanese, M., Bonanno, G., Kerlero de Rosbo, N., & Uccelli, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81039-4 · Cited by 125
Microglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126
“On the contrary, some genetic depletions in microglia revealed neuroprotective outcomes in disease background [13, 48, 104, 106].”
BackgroundSelf-citationPerspectives on Meningoencephalomyelitis of Unknown Origin
Coates, J. R., & Jeffery, N. D. (2014) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2014.07.009 · Cited by 160
Microglial Phenotypes and Functions in Multiple Sclerosis
O’Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028993 · Cited by 124
“Moreover, in models for Parkinson’s and amyotrophic lateral sclerosis (ALS), mice lacking the fractalkine receptor showed significant neuronal loss, showing the potential for microglial neuroprotection via the CX3CR1 receptor (Cardona et al. 2006).”
BackgroundThe Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 125
“The mice lacking CX3CR1, a microglial-associated inflammation factor, exhibited a higher loss of neuron cells than control mice in a PD model established by 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (141).”
BackgroundImpaired Clearance of Apoptotic Cells in Chronic Inflammatory Diseases: Therapeutic Implications
Szondy, Z., Garabuczi, Ã., Joós, G., Tsay, G. J., & Sarang, Z. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00354 · Cited by 124
“Though the elevated levels of apoptotic cells might also be the result of an increased neuronal cell death, in these diseases loss of signaling by fractalkine (an apoptotic cell “find me” signal) resulted in an increase in the number of dying cells and worsening of the disease (22).”
BackgroundDifferential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123
“Furthermore, mice lacking the frac- talkine receptor (CX3CR1), which is expressed by micro- glia and is important for microglia–neuron communication, show extensive neuronal loss in the toxin-induced MPTP PD mouse model (Cardona et al. 2006).”
BackgroundWang, H., Hong, L.-J., Huang, J.-Y., Jiang, Q., Tao, R.-R., Tan, C., Lu, N.-N., Wang, C.-K., Ahmed, M. M., Lu, Y.-M., et al. (2015) · Cell Research · doi:10.1038/cr.2015.61 · Cited by 123
Miao, Y., Zhao, G., Cheng, S., Wang, Z., & Yang, X.-L. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2023.101169 · Cited by 131
Microglia at the blood brain barrier in health and disease
Mayer, M. G., & Fischer, T. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1360195 · Cited by 143
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway
Lee, S., Xu, G., Jay, T. R., Bhatta, S., Kim, K.-W., Jung, S., Landreth, G. E., Ransohoff, R. M., & Lamb, B. T. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0853-14.2014 · Cited by 123
“In the CNS, CX3CL1 is exclusively expressed by neurons and CX3CR1 is exclusively expressed by microglia (Cardona et al., 2006; Kim et al., 2011).”
BackgroundSelf-citationCNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ
Negi, N., & Das, B. K. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1357719 · Cited by 123
“Mice deficient in CX3 C chemokine receptor 1 (CX3CR1) show increased microglial activation and enhanced dopaminergic cell loss in the substantia nigra after lipopolysaccharide (LPS) administration [77].”
BackgroundColes, J. A., Myburgh, E., Brewer, J. M., & McMenamin, P. G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.002 · Cited by 123
“Characterization of immune cells, particularly in the mouse, by use of a large array of transcriptomic markers (Cardona et al., 2006a; Becher et al., 2014; Hume and Freeman, 2014) has enormously increased the number of sub-types and put the nomenclature in flux (Hume et al., 2013; Randolph and…”
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Avila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 123
“In addition to being essential in CNS development and connectivity [233], the CX3CL1–CX3CR1 axis is in the first line of defense in response to neuronal damage and neuroinflammation, exerting neuroprotective signaling [234,235].”
BackgroundFunctional immune cell–astrocyte interactions
Sanmarco, L. M., Polonio, C. M., Wheeler, M. A., & Quintana, F. J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202715 · Cited by 123
Aguzzi, A., & Zhu, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90605 · Cited by 122
Abutbul, S., Shapiro, J., Szaingurten‐Solodkin, I., Levy, N., Carmy, Y., Baron, R., Jung, S., & Monsonego, A. (2012) · Glia · doi:10.1002/glia.22343 · Cited by 122
“Among the known microglial markers, CX3CR1 has drawn extensive attention due to its unique role in maintaining a dialogue with neurons (Cardona et al., 2006).”
BackgroundSelf-citationZhang, F., Vadakkan, K. I., Kim, S. S., Wu, L.-J., Shang, Y., & Zhuo, M. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-15 · Cited by 122
“Monocytes, some NK cells and microglial cells expressed the receptor, CX(3)CR1, and all these cells were reported to be labeled by GFP in Cx3cr1GFP/+ mice [28,29,38,39].”
Microglia in neurodegenerative diseases
Yang, Z.-Y., Jin, W.-L., Xu, Y., & Jin, M.-Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.290881 · Cited by 121
“Microglia are regulated and activated by various signaling pathways, including the nuclear factor kappa B (NF-κB), Tolllike receptors (TLRs), mitogen-activated protein kinases (MAPKs), Janus protein tyrosine kinase-signal transducers and activators of transcription, peroxisome proliferator-activated receptor, Notch, a…”
BackgroundSomera‐Molina, K. C., Robin, B., Somera, C. A., Anderson, C., Stine, C., Koh, S., Behanna, H. A., Van Eldik, L. J., Watterson, D. M., & Wainwright, M. S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01135.x · Cited by 122
“The precise mechanisms by which activated astrocytes and microglia cause neurologic injury remain obscure (Minghetti, 2005; Cardona et al., 2006).”
BackgroundVarvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., & Herrup, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39716 · Cited by 121
“This LPS injection protocol has previously been demonstrated to induce microglia activation within the brain (35).”
BackgroundMicroglial control of neuronal activity
Béchade, C., Cantaut-Belarif, Y., & Bessis, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00032 · Cited by 121
“, 2006), is now demonstrated to be exclusively expressed by microglia (Cardona et al., 2006; Lauro et al., 2008).”
BackgroundModulation of inflammation in transgenic models of Alzheimer’s disease
Birch, A. M., Katsouri, L., & Sastre, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-25 · Cited by 121
“In mouse models of other neurodegenerative disease such as Parkinson’s disease or ALS (amyotrophic lateral sclerosis), lack of CX3CR1 causes widespread neuron loss [63], suggesting that the microglial activation profile seen here is an AD-specific effect.”
BackgroundNeuroimmune Basis of Methamphetamine Toxicity
Loftis, J. M., & Janowsky, A. J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00007-5 · Cited by 130
The Role of Microglia in Modulating Neuroinflammation after Spinal Cord Injury
Brockie, S. T., Hong, J., & Fehlings, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189706 · Cited by 138
“In ischemic injury as well as traumatic brain and spinal cord injury models, functional recovery has been achieved by inhibiting fractalkine signaling [75,77, 78].”
BackgroundMechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
Hickman, S. E., & Khoury, J. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011982 · Cited by 120
“The CX3CL1/CX3CR1 pathway has recently been shown to play a role in microglia neurotoxicity in vivo in mouse models of amyotrophic lateral sclerosis and Parkinson’s disease [59], raising the possibility that it may play a role in regulating microglial functions in AD.”
BackgroundBaron, R., Babcock, A. A., Nemirovsky, A., Finsen, B., & Monsonego, A. (2014) · Aging Cell · doi:10.1111/acel.12210 · Cited by 118
“It has also been argued that microglia showing an activated-like morphology, such as those around Ab plaques in brains affected with Alzheimer’s disease (AD), are in fact maintained quiescent unless peripheral inflammation ensues (Perry et al., 2003; Cardona et al., 2006; Hickman et al., 2008; Streit & Xue, 2009; Abut…”
BackgroundGenetic targeting of microglia
Wieghofer, P., Knobeloch, K.-P., & Prinz, M. (2015) · Glia · doi:10.1002/glia.22727 · Cited by 117
“, 2010), Parkinson’s disease (PD) (Cardona et al., 2006), amyotrophic lateral sclerosis (ALS) (Cardona et al.”
BackgroundMethodInfluentialJaworski, T., Lechat, B., Demedts, D., Gielis, L., Devijver, H., Borghgraef, P., Duimel, H., Verheyen, F., Kügler, S., & LEUVEN, F. V. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.025 · Cited by 132
“Disruption of signaling between neurons and microglia by CX3CL1-CX3CR1 induced neurotoxicity in various mouse models.(48) Conversely, this fractalkine system was neuroprotective in a mouse model of focal cerebral ischemia(49) and in the triple-transgenic mouse model of AD.”
BackgroundNeuroinflammatory priming to stress is differentially regulated in male and female rats
Fonken, L. K., Frank, M. G., Gaudet, A. D., D'Angelo, H. M., Daut, R. A., Hampson, E. C., Ayala, M. T., Watkins, L. R., & Maier, S. F. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.005 · Cited by 118
“Rats received a lethal IP injection of sodium pentobarbital (Fatal-plus; 150 mg/kg), a cardiac blood sample was collected, and then rats were transcardially perfused with 4 C 0.1 M PBS to remove peripheral immune cells from CNS vasculature.”
BackgroundInfluentialEyo, U. B., Peng, J., Murugan, M., Mo, M., Lalani, A., Xie, P., Xu, P., Margolis, D. J., & Wu, L.-J. (2016) · eneuro · doi:10.1523/eneuro.0209-16.2016 · Cited by 116
“Because of the widespread evidence of fractalkine signaling regulating IL-1 (Cardona et al., 2006; Dénes et al., 2008; Rogers et al., 2011), we investigated its role in MPCs. Interestingly, we found that application of 30 ng/mL recombinant mouse IL-1 significantly increased MPCs in slices (Fig.”
BackgroundInfluentialD'Haese, J. G., Demir, I. E., Friess, H., & Ceyhan, G. O. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903540265 · Cited by 116
“The most likely source of fractalkine in the spinal cord in neuropathic pain states are resident microglia which upregulate fractalkine in response to injury [8,10,47].”
BackgroundGuedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115
“In physiological conditions, disruption of CX3CR1 function affects cognitive functions in a IL-1β-dependent manner (60) and exacerbates LPS-induced inflammation (61), suggesting that CX3CR1 maintains microglial homeostasis, being essential for their function in synaptic support and limiting their activation.”
BackgroundAmyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 134
“The modulation of microglial activity in ALS, either by removing the specific downregulatory influence of CX3CL1 (Cardona et al., 2006) or by lowering the levels of mutant SOD1 in”
Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?
Lauro, C., Catalano, M., Trettel, F., & Limatola, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12805 · Cited by 114
Carson, M. J., Bilousova, T. V., Puntambekar, S. S., Melchior, B., Doose, J. M., & Ethell, I. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.002 · Cited by 135
“In vivo and in vitro data demonstrate the potential of microglia to play both beneficial and detrimental roles.(16,17) Whether in vitro or in vivo, blocking neuronal activity with tetrodotoxin immediately leads to increased microglial expression of major histocompatibility complex (MHC) class II.”
Background
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.